CHEN Hai-xia,JIN Feng,WU Wei-li,GAN Jia-ying,LI Yuan-yuan.Analysis of treatment effect of chronomodulated chemotherapy plus concurrent intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma (NPC)[J].Chinese Journal of Radiological Medicine and Protection,2012,32(5):498-501
Analysis of treatment effect of chronomodulated chemotherapy plus concurrent intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma (NPC)
Received:March 06, 2012  
DOI:10.3760/cma.j.issn.0254-5098.2012.05.012
KeyWords:Nasopharyngeal carcinoma  Intensity-modulated radiotherapy  Chronomodulated chemotherapy
FundProject:贵州省科技厅攻关项目(D2008-5)
Author NameAffiliationE-mail
CHEN Hai-xia Department of Head and Neck Oncology, Affiliated Hospital of Guiyang Medical College, Guizhou Tumor Hospital, Guiyang 550004, China  
JIN Feng Department of Head and Neck Oncology, Affiliated Hospital of Guiyang Medical College, Guizhou Tumor Hospital, Guiyang 550004, China jinf8865@sina.com 
WU Wei-li Department of Head and Neck Oncology, Affiliated Hospital of Guiyang Medical College, Guizhou Tumor Hospital, Guiyang 550004, China  
GAN Jia-ying Department of Head and Neck Oncology, Affiliated Hospital of Guiyang Medical College, Guizhou Tumor Hospital, Guiyang 550004, China  
LI Yuan-yuan Department of Head and Neck Oncology, Affiliated Hospital of Guiyang Medical College, Guizhou Tumor Hospital, Guiyang 550004, China  
Hits: 3840
Download times: 2729
Abstract::
      Objective To evaluate the therapeutic effects, acute and late side-effects of cisplatin plus 5-fluorouracil (PF) schemed chronomodulated chemotherapy combined with concurrent intensity-modulated radiotherapy(IMRT) for nasopharyngeal carcinoma.Methods A total of 48 nasopharyngeal carcinoma patients treated with chronomodulated chemotherapy plus concurrent IMRT were retrospectively studied. The radiation doses prescribed to the gross target volume GTVnx of nasopharyngeal, to the positive neck lymphnodes GTVnd, to the clinical target volume CTV1, and to CTV2 were 73.92-77.88, 69.96, 60.06-66.00 and 50.96-56.00 Gy respectively. The Kaplan-Meier survival analysis was used to calculate the local-regional progression-free rate. The acute and late side-effects were graded according to RTOG radiation morbidity scoring criteria.Results The complete remission (CR) rate was 41.6% (20/48); the partial remission (PR) rate was 47.9% (23/48); the stable disease (SD) rate was 4.2% (2/48); and the local tumor control rate was 89.6%. Most of the patients had grade 1 to 2 acute side effects and grade 0 to 1 late side-effects. No grade 4 acute and late toxicity was observed. 1, 2, 4-year survival rates were 93.8%, 79.2% and 64.5%, respectively. The DVH analysis showed that IMRT improved the total dose and dose per-fraction to the target volume with considerable dose reduction of the normal structures at the same time. Conclusions PF chronomodulated chemotherapy plus concurrent intensity-modulated radiotherapy for NPC could improve therapeutic effects with satisfactory tolerance of the side effects.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9057209  On-line:0

v
Scan QR Code
&et=6FD48CA0A0DD475902CE629FDC33872BD183F833047800D3A232BA4019BC617CD63FCEF7E2B64F9AE989CC7CE450D8ECBEFC04D2E5D41CBF02B51630223160CCC63B21D243371B0647CF8476DECBD68064012446ED2A98D3B7C49490B4F7DF566085BA12D27199A753D889E37BE232C60D147E4B203BF63E31B3EE662098030667EA6EC65FBC3167A4DC7A1765F067453C5BF1A2F05FB8F8EBFD8798831591A1&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=99E9153A83D4CB11&aid=82F2CF3652F698A6BA7D7AFD4898501D&vid=&iid=94C357A881DFC066&sid=E3C3E274D87A8C16&eid=3054A11AD1D7E34A&fileno=20120512&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="99E9153A83D4CB11"; var my_aid="82F2CF3652F698A6BA7D7AFD4898501D";